DXCM DEXCOM INC Legal Disputes 8-K Filing 2024 - Patent Settlement Dexcom and Abbott have settled their patent litigation by entering into a cross-licensing agreement that allows both companies to use each other's patents without paying royalties until December 2034.Get access to all SEC 8-K filings of the DEXCOM INC